Department of Neurology, the First Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, China.
Neural Regen Res. 2013 Nov 25;8(33):3116-23. doi: 10.3969/j.issn.1673-5374.2013.33.005.
A previous study of European Caucasian patients with sporadic amyotrophic lateral sclerosis demonstrated that a polymorphism in the microtubule-associated protein Tau (MAPT) gene was significantly associated with sporadic amyotrophic lateral sclerosis pathogenesis. Here, we tested this association in 107 sporadic amyotrophic lateral sclerosis patients and 100 healthy controls from the Chinese Han population. We screened the mutation-susceptible regions of MAPT - the 3' and 5' untranslated regions as well as introns 9, 10, 11, and 12 - by direct sequencing, and identified 33 genetic variations. Two of these, 105788 A > G in intron 9 and 123972 T > A in intron 11, were not present in the control group. The age of onset in patients with the 105788 A > G and/or the 123972 T > A variant was younger than that in patients without either genetic variation. Moreover, the pa-tients with a genetic variation were more prone to bulbar palsy and breathing difficulties than those with the wild-type genotype. This led to a shorter survival period in patients with a MAPT genetic variant. Our study suggests that the MAPT gene is a potential risk gene for sporadic amyotrophic lateral sclerosis in the Chinese Han population.
先前一项针对欧洲白种散发型肌萎缩侧索硬化症患者的研究表明,微管相关蛋白 Tau(MAPT)基因的多态性与散发型肌萎缩侧索硬化症的发病机制显著相关。在此,我们在来自中国汉族人群的 107 名散发型肌萎缩侧索硬化症患者和 100 名健康对照中检验了这种相关性。我们通过直接测序筛选了 MAPT 的突变易感区域——3'和 5'非翻译区以及内含子 9、10、11 和 12——并鉴定出 33 种遗传变异。其中两种,即内含子 9 中的 105788A>G 和内含子 11 中的 123972T>A,在对照组中不存在。携带 105788A>G 和/或 123972T>A 变异的患者的发病年龄比没有这两种遗传变异的患者年轻。此外,携带遗传变异的患者比野生型基因型的患者更容易出现延髓性麻痹和呼吸困难,导致携带 MAPT 遗传变异的患者的生存周期更短。我们的研究表明,MAPT 基因是中国汉族人群散发型肌萎缩侧索硬化症的一个潜在风险基因。